Lundkvist, P., Sjöström, C. D., Amini, S., Pereira, M. J., Johnsson, E., & Eriksson, J. W. (2016). Dapagliflozin once‐daily and exenatide once‐weekly dual therapy: A 24‐week randomized, placebo‐controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes. Diabetes Obes Metab.

Lundkvist, Per, C. David Sjöström, Sam Amini, Maria J. Pereira, Eva Johnsson, and Jan W. Eriksson. "Dapagliflozin Once‐daily and Exenatide Once‐weekly Dual Therapy: A 24‐week Randomized, Placebo‐controlled, Phase II Study Examining Effects On Body Weight and Prediabetes in Obese Adults Without Diabetes." Diabetes Obes Metab 2016.

Lundkvist, Per, et al. "Dapagliflozin Once‐daily and Exenatide Once‐weekly Dual Therapy: A 24‐week Randomized, Placebo‐controlled, Phase II Study Examining Effects On Body Weight and Prediabetes in Obese Adults Without Diabetes." Diabetes Obes Metab 2016.